Stock Events

Stock Events

Kaken Pharmaceutical (4521.TSE) Q2 2026 Earnings

May 13Confirmed

Q3 2025

Q4 2025

Q1 2026

Q2 2026

7

13

19

25

Details

Expected EPS

20

Actual EPS

20

Surprise EPS

-0

Surprise Percent

-1.43%

Description

⁨Kaken Pharmaceutical⁩ (⁦4521.TSE⁩) has reported earnings of ⁦20⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.